The ethics of Zika trials in pregnancy

Exploring the ethics of involving pregnant women in clinical trials for diagnostic tests, treatments and vaccines for Zika virus is one of five new research projects funded by the Wellcome Trust and the Department for International Development as part of the UK’s response to the outbreak.

Pregnant women are thought to be especially vulnerable to Zika because of the reported link to fetal abnormalities, yet this group is often automatically excluded from medical research because of safety concerns.

Now, researchers at John Hopkins University, USA, will devise rapid guidelines for carrying out ethically responsible studies with pregnant women during Zika and other global health emergencies.

This guidance is needed to ensure that any new medicines that are developed, such as a Zika vaccine, are made available to those most at risk from the virus.

Other scientists to receive funding include:

The latest projects bring Wellcome’s total commitment to Zika research to around £2.8 million.

Last month, we announced support for 26 proposals funded jointly with the Medical Research Council through their Zika Rapid Response Initiative.